Arteris, Inc. (NASDAQ:AIP - Get Free Report) CFO Nicholas B. Hawkins sold 3,889 shares of the firm's stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $8.99, for a total value of $34,962.11. Following the completion of the transaction, the chief financial officer owned 135,496 shares in the company, valued at approximately $1,218,109.04. This represents a 2.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Arteris Stock Up 0.7%
NASDAQ AIP traded up $0.06 during trading on Monday, reaching $9.29. 539,679 shares of the stock traded hands, compared to its average volume of 229,363. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $12.64. The firm has a market cap of $389.99 million, a price-to-earnings ratio of -11.33 and a beta of 1.44. The stock's 50-day moving average price is $7.95 and its 200 day moving average price is $8.56.
Hedge Funds Weigh In On Arteris
A number of hedge funds and other institutional investors have recently made changes to their positions in AIP. G2 Investment Partners Management LLC bought a new stake in shares of Arteris in the 4th quarter valued at $2,799,000. Charles Schwab Investment Management Inc. boosted its holdings in Arteris by 4.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company's stock worth $802,000 after purchasing an additional 3,298 shares during the last quarter. BNP Paribas Financial Markets bought a new position in Arteris in the fourth quarter valued at $214,000. Two Sigma Advisers LP increased its stake in Arteris by 82.9% in the 4th quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock valued at $240,000 after buying an additional 10,700 shares during the last quarter. Finally, EAM Investors LLC bought a new stake in Arteris during the 4th quarter worth about $983,000. 64.36% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, Rosenblatt Securities restated a "buy" rating and set a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st.
Get Our Latest Stock Report on Arteris
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
